BSX : WATCHMAN FLX Device Reduces Bleeding Risk, Matches Stroke Prevention After Cardiac Ablation
17/11 04:05
(RTTNews) - Boston Scientific Corp. (BSX) announced positive three-year primary endpoint results from the OPTION global clinical trial of the WATCHMAN FLX Left Atrirl Appendage Closure (LAAC) Device. The device demonstrated superior bleeding risk Reduction to oral Anticoagulation...